Alnylam Going After World's Most Expensive Drug in New TrialsBy
CEO says $440,000 price on existing drug gives room to compete
Alnylam says experimental drug will be in late trials in 2017
Alnylam Pharmaceuticals Inc. is taking on the world’s most expensive drug, betting that its experimental treatment for a rare disease can compete in a narrow market dominated by one pricey therapy.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.